Tracy L Simpson1,2, Peter Rise3, Kendall C Browne1,2,4, Keren Lehavot2,3,5, Debra Kaysen2. 1. Center of Excellence in Substance Abuse and Treatment (CESATE), VA Puget Sound Health Care System, Seattle, WA, USA. 2. Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA. 3. Denver-Seattle Center of Innovation for Veteran-Centered Value-Driven Care, VA Puget Sound Health Care System, Seattle, WA, USA. 4. Center of Excellence in Substance Abuse and Treatment (CESATE), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA. 5. Department of Health Services, University of Washington, Seattle, WA, USA.
Abstract
AIMS: To compare individuals with comorbid life-time post-traumatic stress disorder (PTSD) and alcohol use disorders [AUD; i.e. no drug use disorders (DUD)] with those with comorbid PTSD and DUD on past-year prevalence of these disorders, social functioning, life-time psychiatric comorbidities, and treatment receipt. The comorbid groups were also compared with their single diagnosis counterparts. DESIGN AND SETTING: Cross-sectional cohort study using data from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC-III). PARTICIPANTS: The total sample size was 36 309. Six groups were established: PTSD/AUD, PTSD/DUD, AUD, DUD, PTSD, and neither PTSD nor AUD/DUD. Life-time prevalence of AUD among those with PTSD/DUD was 80.2% and among those with DUD was 73.8%. MEASUREMENTS: The Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-5 version assessed life-time and past-year psychiatric disorders and treatment receipt. Demographics and social stability indicators were queried. Group characteristics were summarized using weighted means. Prevalences and estimates for adjusted differences in means and adjusted odds ratios (aORs) were derived from multiple linear regression and logistic regression models, respectively. Analyses were conducted in R and accounted for the NESARC-III's complex survey design, clustering, and non-response. FINDINGS: Compared with those with life-time PTSD/AUD, those with life-time PTSD/DUD were significantly less likely to have neither disorder in the past year (PTSD/AUD = 16.1%; PTSD/DUD = 8.5%; aOR = 0.54), and were more likely to report worse social and psychiatric functioning, and to have received both addiction and mental health treatment (PTSD/AUD = 18.4%; PTSD/DUD = 43.2%; aOR = 3.88). Compared with their single disorder counterparts, those with PTSD/DUD reported greater impairment than both groups, whereas the comorbid PTSD/AUD group differed more from the AUD than the PTSD group. CONCLUSIONS: People with comorbid PTSD and drug use disorder have greater social and psychiatric impairment and may require different types and intensity of intervention than people with comorbid post-traumatic stress disorder and alcohol use disorder.
AIMS: To compare individuals with comorbid life-time post-traumatic stress disorder (PTSD) and alcohol use disorders [AUD; i.e. no drug use disorders (DUD)] with those with comorbid PTSD and DUD on past-year prevalence of these disorders, social functioning, life-time psychiatric comorbidities, and treatment receipt. The comorbid groups were also compared with their single diagnosis counterparts. DESIGN AND SETTING: Cross-sectional cohort study using data from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC-III). PARTICIPANTS: The total sample size was 36 309. Six groups were established: PTSD/AUD, PTSD/DUD, AUD, DUD, PTSD, and neither PTSD nor AUD/DUD. Life-time prevalence of AUD among those with PTSD/DUD was 80.2% and among those with DUD was 73.8%. MEASUREMENTS: The Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-5 version assessed life-time and past-year psychiatric disorders and treatment receipt. Demographics and social stability indicators were queried. Group characteristics were summarized using weighted means. Prevalences and estimates for adjusted differences in means and adjusted odds ratios (aORs) were derived from multiple linear regression and logistic regression models, respectively. Analyses were conducted in R and accounted for the NESARC-III's complex survey design, clustering, and non-response. FINDINGS: Compared with those with life-time PTSD/AUD, those with life-time PTSD/DUD were significantly less likely to have neither disorder in the past year (PTSD/AUD = 16.1%; PTSD/DUD = 8.5%; aOR = 0.54), and were more likely to report worse social and psychiatric functioning, and to have received both addiction and mental health treatment (PTSD/AUD = 18.4%; PTSD/DUD = 43.2%; aOR = 3.88). Compared with their single disorder counterparts, those with PTSD/DUD reported greater impairment than both groups, whereas the comorbid PTSD/AUD group differed more from the AUD than the PTSD group. CONCLUSIONS:People with comorbid PTSD and drug use disorder have greater social and psychiatric impairment and may require different types and intensity of intervention than people with comorbid post-traumatic stress disorder and alcohol use disorder.
Authors: Bridget F Grant; Rise B Goldstein; Sharon M Smith; Jeesun Jung; Haitao Zhang; Sanchen P Chou; Roger P Pickering; Wenjun J Ruan; Boji Huang; Tulshi D Saha; Christina Aivadyan; Eliana Greenstein; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2014-12-08 Impact factor: 4.492
Authors: Miriam K Forbes; Julianne C Flanagan; Emma L Barrett; Erica Crome; Andrew J Baillie; Katherine L Mills; Maree Teesson Journal: Drug Alcohol Depend Date: 2015-09-14 Impact factor: 4.492
Authors: Shannon M Blakey; Sarah C Griffin; Jeremy L Grove; Samuel C Peter; Ryan D Levi; Patrick S Calhoun; Eric B Elbogen; Jean C Beckham; Mary J Pugh; Nathan A Kimbrel Journal: J Affect Disord Date: 2022-04-07 Impact factor: 6.533
Authors: Lisa M Najavits; H Westley Clark; Carlo C DiClemente; Marc N Potenza; Howard J Shaffer; James L Sorensen; Matthew T Tull; Allen Zweben; Joan E Zweben Journal: Curr Treat Options Psychiatry Date: 2020-09-24
Authors: Rebecca J Evans-Polce; Luisa Kcomt; Philip T Veliz; Carol J Boyd; Sean Esteban McCabe Journal: Am J Psychiatry Date: 2020-09-11 Impact factor: 18.112
Authors: Sudie E Back; Kevin Gray; Elizabeth Santa Ana; Jennifer L Jones; Amber M Jarnecke; Jane E Joseph; James Prisciandaro; Therese Killeen; Delisa G Brown; Linda Taimina; Ebele Compean; Robert Malcolm; Julianne C Flanagan; Peter W Kalivas Journal: Contemp Clin Trials Date: 2020-02-19 Impact factor: 2.226
Authors: Shannon M Blakey; Kirsten H Dillon; H Ryan Wagner; Tracy L Simpson; Jean C Beckham; Patrick S Calhoun; Eric B Elbogen Journal: Psychol Trauma Date: 2021-03-04
Authors: Tracy L Simpson; Simon B Goldberg; Diana K N Louden; Shannon M Blakey; Sage E Hawn; Aline Lott; Kendall C Browne; Keren Lehavot; Debra Kaysen Journal: J Anxiety Disord Date: 2021-10-26
Authors: Melissa J Zielinski; Mollee K Steely Smith; Debra Kaysen; James P Selig; Nickolas D Zaller; Geoffrey Curran; JoAnn E Kirchner Journal: Health Justice Date: 2022-10-01